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Binding of Benzidine, N-Acetylbenzidine,
N, N'-Diacetylbenzidine and Direct Blue 6
to Rat Liver DNA
by C. N. Martin,* F. A. Beland,tJ. C. Kennelly*
and F. F. Kadlubart
Studies were performed to assess covalent binding of [3H]benzidine, [14C]N-acetylbenzidine,
['4C]N, N-diacetylbenzidine, and the benzidine-derived azo dye Direct Blue 6 to rat hepatic DNA.
Following IP injection into male Sprague-Dawley rats, benzidine and N-acetylbenzidine bound to
liver DNA to yield the same adduct: N4deoxyguanosin-8-yl)N'-acetylbenzidine. The isomeric N-
(deoxyguanosin-8-yl-N-acetylbenzidine and the deacetylated adductN4deoxyguanosin-8-yl) benzidine
were also synthesized, but neither of these adducts was detected in vivo. Injection of N,N'-
diacetylbenzidine resulted in only barely detectable binding which was insufficient for adduct anal-
ysis. [3H]Direct Blue 6 was administered to male Wistar rats either by IP injection or by gavage. In
both instances, Direct Blue 6 bound covalently to liver DNA; however, binding occurred at a much
higher level in the IP injected animals. With IP injected animals, high pressure liquid chromato-
graphic analysis indicated that approximately 70% of the radioactivity was associated with N-
(deoxyguanosin-8-yl) benzidine.
Introduction
Benzidine (BZ) has been shown to induce tumors
at various sites in laboratory animals (1, 2). The ma-
jor target organ in the rat and mouse is the liver,
whereas tumors of the bladder are observed in
dogs. BZ is also known to be responsible for the in-
duction of bladder cancer in humans occupationally
exposed to this compound (3, 4). Morton et al. (5)
have shown in vitro that BZ can be sequentially
acetylated to N-acetylbenzidine (ABZ) and N,N'-
diacetylbenzidine (DABZ). This latter species was
then demonstrated to be a substrate for hepatic
N,O-acyltransferase (5, 6) and hepatic sulfotransfer-
ase (7) and to form reactive intermediates that
would covalently bind to nucleophiles. More re-
cently, Morton and co-workers (8) reported that BZ
and N-hydroxy-DABZ were more carcinogenic than
DABZ in rats; however, the metabolic activation
pathways responsible for tumor induction were not
elucidated.
The BZ-derived azo dye, Direct Blue 6 (DBU6),
will induce liver tumors in rats after a relatively
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short exposure period (9). When this or other BZ-
based dyes are administered to animals, including
man, BZ and its acetylated derivatives are detect-
able as urinary metabolites (10-13). Therefore, it has
been suggested that the carcinogenicity of these
compounds is likely to result from the action of the
parent amine upon its release by microbial reduc-
tion of the dye in the alimentary tract. No data are
yet available, however, to indicate the precise mech-
anism by which such compounds induce tumors.
The work reported here and described in greater
detail elsewhere (14) was initiated to determine the
nature of the BZ-DNA adducts found in rat liver fol-
lowing administration of [3HJBZ. Preliminary studies
have also been performed on the DNA binding char-
acteristics of [3H]DBU6 in rats treated by IP injec-
tion or by gavage. Eventually, we hope to charac-
terize the DNA adduct(s) formed from DBU6 and,
by comparison with BZ, elucidate the pathway(s) by
which such azo dyes are activated in vivo.
Materials and Methods
Animals
Experiments involving BZ, ABZ, and DABZ were
performed with male Sprague-Dawley rats (9-23
weeks old, 250-350 g) obtained from the NCTRMARTINETAL.
breeding colony and fed a pelleted Basal Diet (No.
5755C, Ralston Purina, St. Louis MO) ad libitum.
Experiments involving DBU6 were performed with
males of a Wistar-derived strain purchased from
Bantin and Kingman, Ltd., Hull, UK, and fed diet
41B (Oxoid Ltd., London, UK).
Chemicals
All chemicals used were of analytical reagent
grade. BZ, [ring_14C]BZ (14.1 mCi/mmole), [ring-
14C]ABZ (17.9 mCi/mmole) and [ring_14C]DABZ (17.1
mCi/mmole) were obtained from Dr. William P.
Duncan, Midwest Research Institute, Kansas City,
MO. [Acetyl-3H]ABZ (45 mCilmmole), [2,2'-3H]BZ (115
mCi/mmole), and [2,2_-3H N-hydroxy-N'-ABZ (24.7
mCi/mmole) were synthesized by Dr. R. Roth of the
Midwest Research Institute according to published
procedures (14).
Preparation of [Ring-3H]BZ
[Ring-3H]BZ was synthesized from [ring-3H]aniline
(150 mCilmmole) which was obtained from Radio-
chemical Centre, Amersham, UK. [3H]Aniline (15.53
mg) was dissolved in 2.5 mL glacial acetic acid, 26
mg nitrosobenzene was added, and the reaction mix-
ture was stirred overnight at room temperature.
After centrifugation to remove unreacted nitroso-
benzene, the supernatant which contained [ring-
3H]azobenzene was added to 5 mL hexane. The pre-
cipitate of nitrosobenzene was collected by centrifu-
gation, was washed with hexane, and the washings
were added to the hexane/acetic acid mixture. The
solution of azobenzene was extracted with water
and evaporated under reduced pressure. The [ring-
3H]azobenzene was then reduced and rearranged
(15) to yield [ring-3H]BZ (128 mCVmmole; yield:
61.8% of theoretical).
Preparation of [Ring-3H]DBU6
[Ring-3H]BZ (128 mCi/mmole, 6.67 mg) was
dissolved in 3 mL water which contained 22 ,.L con-
centrated HCl. The solution was cooled in ice and 5
mg NaNO2 (1 mg/mL in water) was added dropwise
until there was a slight excess of oxidant as shown
by starch iodide paper. The solution was adjusted to
pH 9 with saturated sodium carbonate and then
23.14 mg 1-naphthol-8amine-3,6-disulfonic acid (H-
acid; ICI Stevenston, Ayreshire, UK) in sodium car-
bonate solution, pH 9, was added. After 10 min, the
reaction mixture was extracted twice with dichloro-
methane to remove any unreacted [3H]BZ and then
freeze dried. The synthetic [3H]DBU6 was coin-
jected with an authentic standard onto a Partisil-10
ODS-2 analytical column (Whatman, Maidstone,
Kent, UK) and eluted with a gradient of 1% cetri-
mide, pH 3 (A): 1% cetrimide in n-propanol (B). The
gradient conditions were 20% B over 10 min, rising
to 100% B over the next 15 min. Visible absorptiv-
ity was monitored at 580 nm and half-minute frac-
tions were collected for scintillation counting. DBU6
eluted after 22 min and its radiochemical purity was
>98%.
Binding of BZ, ABZ, and DABZ to Rat
Liver DNAIn Vivo
One male rat was injected IP with [2,2'-3H]BZ,
two rats were injected IP with [ring-14C]ABZ, two
with [ring-4C]DABZ and three with [acetyl-
3H]ABZ. In each case, the dose administered was 25
mg/kg. Animals were killed 24 hr later by decapita-
tion, and their livers were removed. DNA was
isolated and purified by chloroform:isoamyl alco-
hol:phenol extraction and hydroxylapatite chroma-
tography (14, 16). Dried DNA samples were dis-
solved at 2 mg/mL in 5 mM Bis-Tris-HCl buffer, pH
7.1, which contained 5 mM MgCl2. Aliquots of this
solution were used for colorimetric estimation of
DNA (17) and for scintillation counting to determine
total DNA binding. Samples were then enzymati-
cally hydrolyzed and prepared for reversed-phase
HPLC analysis by extraction of the adduct into n-
butanol (14). Only one peak of radioactivity
was eluted from the column following injection of
samples from either BZ- or ABZ-treated animals.
Fractions associated with this peak were pooled and
used to determine the pH-dependent solvent parti-
tioning profile of the adduct (18).
Reaction ofN-Hydroxy-N'-ABZ With DNA
[2,2'-3H]N-Hydroxy-N'-ABZ [2 mL of 25 mM solu-
tion in ethanol: DMSO (4:1)] was reacted with 500
mg calf thymus DNA in 100 mL argon-saturated 10
mM potassium citrate/i mM EDTA buffer, pH 4.6.
After 4 hr, the DNA was isolated (19), enzymatically
hydrolyzed and prepared for HPLC analysis in the
same manner as the in vivo samples. The major ad-
duct peak was purified on a Waters CQ8-uBondapak
Semiprep column by eluting with 45% methanol at
a flow rate of 4 ml/min. The adduct was charac-
terized by NMR and mass spectroscopy (14). A pH-
dependent solvent partitioning profile was obtained
and compared with that of the adduct formed in
vivo from BZ or ABZ. The synthetic adduct was
also coinjected with the radiolabeled in vivo adduct
onto an analytical reversed-phase column. The
column was eluted at 2 mL/min with 20% methanol
in water for 10 min followed by a linear gradient
over 10 min to 70% ethanol, and then increasing to
100% methanol over 5 min. UV absorbance was
monitored at 282 nm and half-minute fractions were
collected for scintillation counting.
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Carboxylesterase Treatment of Adducts
The purified synthetic adduct (1 mg) obtained as
described above was dissolved in 100,L DMSO and
added to 10 mL 50 mM potassium phosphate buffer,
pH 7.7. Carboxylesterase I and II (80 units each)
were added and the mixture was incubated at 370C
for 4 hr. The single product was purified on prepar-
ative HPLC and was characterized by NMR and
mass spectral analysis. The product of reaction be-
tween N-acetoxy-DABZ and deoxyguanosine was
treated similarly and the final product was charac-
terized by mass and NMR spectral measurements.
Binding of DBU6 to Rat Liver DNA
A total of 10 rats were treated with [ring-
3H]DBU6. Half of the animals were injected IP at a
dose of 12 mg/kg, and the remaining rats were
treated at the same dose by gavage. One rat from
each group was killed at 2, 8, 24, 48, and 168 hr after
treatment. Livers were removed and DNA was ex-
tracted and purified as described above. Aliquots of
washed liver (100 mg) were dissolved in 2 mL of
Soluene (Packard Instrument Co., Illinois, USA) and
counted for radioactivity to determine total uptake
of dye. Purified DNA was estimated colorimetri-
cally and associated radioactivity determined by
scintillation counting. Samples at 24 and 168 hr
were enzymically hydrolyzed and analyzed on
HPLC as described for BZ- and ABZ-modified DNA.
Results
Covalent Binding of BZ, ABZ and DABZ to
Rat Liver DNA
[2,2'-3H]BZ, [ring-14C]ABZ and [acetyl-3H]ABZ all
bound covalently to rat liver following IP injection
(Table 1). Enzymic hydrolysis and subsequent
HPLC analysis of liver DNA from BZ- and ABZ-
treated animals each resulted in detection of only
one peak of radioactivity which coeluted at 19.5 min
on an analytical HPLC reversed-phase column (Fig.
Table 1. Covalent binding of BZ, ABZ and DABZ
to rat liver DNA.a
Treatment pmole bound/mg DNA
[ring-3H]BZ 48
[ring-3H]ABZ 56-89
[acetyl-3H]ABZ 61-72
[ring-3H]DABZ NDb
aMale rats were administered the compounds IP at 25
mg/kg and then killed after 24 hr. Hepatic DNA was isolated
and quantified by the diphenylamine reaction, and the specific
activity was determined by scintillation counting.
bND = not detected. The limit of detection was <0.3 pmole
bound/mg DNA.
1). This suggested that the major DNA adduct
induced in rat liver in vivo by BZ was identical to
that induced by ABZ. The elution of a single peak of
radioactivity at 19.5 min in [acetyl-3H]ABZ-treated
animals confirmed that the adduct was acetylated.
When pH-dependent solvent partitioning ex-
periments were performed on the purified DNA
adduct from both BZ- or ABZ- treated animals,
similar profiles were also observed (Fig. 2).
20 r
16p
12!-
a C.)
0
x
ci
8
4 [
/
/
/
/
/
/1
of IV///A77I
10 20
100
80 a
60 g
0
40 1
20
0
30
Time (min)
FIGURE 1. HPLC profile of liver DNA from BZ-treated rat. A
male rat was inject IP with [2,2'-3H]BZ and killed after 24
hr. Liver DNA was isolated, enzymatically hydrolyzed,
and the adduct fraction was partitioned into n-butanol.
Analysis was performed on a Whatman Partisil-10 ODS-2
column with the gradient indicated at a flow of 2 mL/min.
The same profile was observed with [ring-14C]ABZ and
[acetyl-3H]ABZ-treated rats.
Reaction ofN-Hydroxy-N'-ABZ With DNA
[2,2'-3HWN-Hydroxy-NY-ABZ was reacted with
DNA at 370C and the single adduct that formed
was isolated after enzymic hydrolysis and extrac-
tion into n-butanol. Purification by reversed-phase
HPLC yielded a product which was characterized
by NMR and mass spectroscopy as NAdeoxyguano-
sin-8-yl-N'-ABZ. The pH-dependent solvent parti-
tioning profile (Fig. 2) and the chromatographic
profile were identical to those obtained from the
major in vivo adduct of either BZ or ABZ. This
evidence, combined with pH stability and deacetyla-
tion data (14), confirmed the identity of the in vivo
adduct as beingN-deoxyguanosin-8yl-N'-ABZ.
Synthesis ofN(Deoxyguanosin-8-yl)NABZ
andN(Deoxyguanosin-8-yl)BZ
The isomeric acetylated derivative N-(deoxyguan-
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osin-8-yl-N-ABZ was synthesized by carboxylester-
ase-mediated, selective deacetylation of N-(deoxygu-
anosin-8-yl)N,N'-DABZ. The deacetylated adduct N-
(deoxyguanosin-8-yl)BZ was similarly synthesized
from N-(deoxyguanosin-8-yl-N'-ABZ. Both com-
pounds were characterized by their mass and NMR
spectra (14). The two acetylated and one deacety-
lated synthetic DNA adducts were coinjected onto
an analytical reversed-phase HPLC column and all
three compounds were well separated (Fig. 3). The
N-butanol-extractable fraction of hydrolyzed liver
DNA from rats treated with either BZ or ABZ was
coinjected with these three marker compounds and
radioactivity was found associated only with N-de-
oxyguanosin-8-yl)N'-ABZ.
Binding of DBU6 to Rat Liver DNA
Rats were administered [ring-3H]-DBU6 either by
* / gavage or by IP injection. Animals were killed at
.\ . * . . various times after treatment and total binding to
601 = / liver tissue was measured (Table 2). Following ex-
A. *._U *traction and purification, covalent binding to liver
DNA was also measured (Table 2). In the case of or-
ally dosed animals a small amount of DNA binding,
which increased with time, was observed. A much
50 ,_,_,_,_,_,_ ,larger extent of DNA binding was detected in IP in-
1 3 5 7 9 11 13 jected animals. Samples from these latter rats were
pH enzymically hydrolyzed and the adducts were ana-
;URE 2. pH-dependent solvent partitioning profile of N- lyzed by reversed-phase HPLC. Approximately
(deoxyguanosin-8-yl)-N'-ABZ (0) formed in vivo by in- 70% of the activity coeluted withNdeoxyguanosin-
jection of rats with BZ; (A) from injection of rats with 8-yl-BZ while the remaining 30% eluted later and
ABZ; (U) synthesized by reaction of N-hydroxy-N'-ABZ has been tentatively identified as the deribosylated
with deoxyguanosine. derivative.
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FIGURE 3. Coinjection onto a Partisil-10 ODS-2-reversed-
phase HPLC column of (A) N-(deoxyguanosin-8-yl)-N-ABZ,
(B) N-(deoxyguanosin-8-yl)-BZ and (C) N-(deoxyguanosin-8-
yl-N'-ABZ.
Table 2. Total uptake of [3H]DBU6 by rat liver
and binding to DNA.
Time after Adminis- Radioactivity,
treatment, tration nCi/mg Total binding,
hr route tissuea nmole/mole DNA (P)b
2 Oral 0.03 12
IP 2.09 61
8 Oral 0.11 33
IP 5.43 1589
24 Oral 0.12 64
IP 5.46 1069
48 Oral 0.06 76
IP 4.81 1384
168 Oral 0.06 111
IP 7.16 7656
aAliquots of washed liver (100 mg) were dissolved in 2 mL
of Soluene and the extent of radioactivity was determined by
liquid scintillation counting.
bHepatic DNA was isolated and quantified by the
diphenylamine reaction and the specific activity was deter-
mined by scintillation counting.
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Discussion
In vitro studies by Morton et al. (5) have shown
that N,N'-diacetylation of BZ occurred prior to N-
hydroxylation. The hydroxamic acid produced by
these two reactions could then be converted to a re-
active species by cytosolic N,O-acyltransferase (5,6)
or sulfotransferase (7). It was unclear, however, as
to the pathway which led to the in vivo production
of an electrophile capable of covalent reaction with
cellular DNA. IP injection of either [ring-14C]ABZ or
[2,2'-3H]BZ into rats resulted in the formation of the
same DNA adduct. To determine whether acety-
lation of BZ or deacetylation of ABZ occurred, rats
were injected with [acetyl-3H]ABZ. The production
of the same radiolabelled adduct confirmed that N-
acetylation of BZ is the first step in its activation in
rats. That N-hydroxylation of DABZ occurred to an
appreciable extent in vivo seemed unlikely as injec-
tion of [ring-14C]DABZ resulted in very low binding
to DNA. To examine the possibility thatN-hydroxy-
lation may occur at the free amine of ABZ, N-hy-
droxy-N'-ABZ was synthesized and allowed to react
with DNA at room temperature. Following hydroly-
sis of the DNA and chromatographic purification,
the product was determined to be N(deoxyguano-
sin-8-yl)N'-ABZ. A variety of procedures, including
cochromatography after incubation with base, acid,
or carboxylesterase, and pH-dependent solvent par-
titioning, confirmed that the in vivo adduct and the
synthetic marker were identical. The isomericN-de-
oxyguanosin-8-yl)N-ABZ and the deacetylated ad-
ductN-deoxyguanosin-8yl)BZ werealsosynthesized
and were well separated from the in vivo adduct by
HPLC. Therefore, as the deacetylated adduct was
not detected in vivo, it may be assumed that N-
hydroxy-BZ or N-hydroxy-N-ABZ are not proximate
carcinogenic species in hepatocarcinogenesis in rats.
Furthermore, diacetylated adducts were not found,
which demonstrates that if N-hydroxy-DABZ was
formed during metabolism, it does not act as a sub-
strate for sulfotransferase enzymes. Thus, N-hy-
droxy-N'-ABZ, whether formed by sequentialN-acet-
ylation and N'-hydroxylation of BZ or by deacetyla-
tion ofN-hydroxy-DABZ, appears a strongcandidate
proximate carcinogenic species of BZ and ABZ. N-
Hydroxy-N'-ABZ may, of course, be further acti-
vated by O-esterification or by intermolecular N,0-
acyltransfer(20).
Direct Blue 6 is a polar dye derived from BZ by
coupling it to two molecules of H-acid via diazo link-
ages. It has been suggested that the carcinogenicity
of this and similar dyes results from reductive
cleavage of the diazo bonds with consequent release
of free BZ (10, 21-23). Such reduction can occur as a
result of action by gut microflora (22) or possibly
by mammalian liver enzymes (24, 25). Covalent bind-
ing of DBU6 to rat liver DNA occurred in animals
dosed with [ring-3H]DBU6 either by gavage or by
IP injection. Total binding following IP injection
was greater than that observed in orally treated an-
imals. Total binding was greatest in the 7-day ani-
mals which could be explained by the slow release
of the dye from tissues to which it is bound by ionic
interaction. In contrast to the ABZ adduct obtained
from BZ and ABZ treatments, the major adduct
which resulted from DBU6 administration coeluted
with N-deoxyguanosin-8-yl)BZ. It would appear
from these preliminary data that metabolism of the
azo dye is not as simple as reduction to BZ before
activation to form a reactive intermediate.
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